CTT Pharmaceutical Holdings Inc CTTH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.03–0.04
- 52-Week Range
- $0.00–0.10
- Bid/Ask
- $0.03 / $0.04
- Market Cap
- $1.65 Mil
- Volume/Avg
- 9,600 / 32,564
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 2
Valuation
|
Metric
|
CTTH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CTTH
Financial Strength
|
Metric
|
CTTH
|
|---|---|
Quick Ratio | 3.40 |
Current Ratio | 3.40 |
Interest Coverage | — |
Quick Ratio
CTTH
Profitability
|
Metric
|
CTTH
|
|---|---|
Return on Assets (Normalized) | −217.23% |
Return on Equity (Normalized) | −741.62% |
Return on Invested Capital (Normalized) | −741.62% |
Return on Assets
CTTH
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Knynmwshjk | Cmhc | $76.9 Bil | |
MKKGY
| Merck KGaA ADR | Yrvgsjmq | Lqvdq | $72.0 Bil | |
HLN
| Haleon PLC ADR | Lbxjtkgn | Wfgb | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Xcwjvqnn | Bfmw | $17.9 Bil | |
VTRS
| Viatris Inc | Dqjlgzbs | Nbkjc | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Csjdvgwyp | Bgdz | $11.7 Bil | |
CTLT
| Catalent Inc | Xblntlc | Wvssvn | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Fmxqfxvy | Nmvt | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Rhbmmbyf | Lws | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vjqbwlwb | Yqqdpx | $3.5 Bil |